{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T06:11:30Z","timestamp":1792649490895,"version":"4.5.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.atherosclerosis.2025.120523","type":"journal-article","created":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T23:04:21Z","timestamp":1759359861000},"page":"120523","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Clinical impact of systemic inflammation across different high-sensitivity C-reactive protein cutoffs in patients undergoing percutaneous coronary intervention"],"prefix":"10.1016","volume":"410","author":[{"given":"Angelo","family":"Oliva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Shneyderman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Gitto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Sartori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgit","family":"Vogel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Bay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Sweeny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca Maria","family":"Di Muro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulio","family":"Stefanini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annapoorna S.","family":"Kini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George D.","family":"Dangas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samin K.","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5546-262X","authenticated-orcid":false,"given":"Roxana","family":"Mehran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"16","key":"10.1016\/j.atherosclerosis.2025.120523_bib1","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMra043430","article-title":"Inflammation, atherosclerosis, and coronary artery disease","volume":"352","author":"Hansson","year":"2005","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.atherosclerosis.2025.120523_bib2","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1161\/01.CIR.98.9.839","article-title":"Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events (CARE) investigators","volume":"98","author":"Ridker","year":"1998","journal-title":"Circulation"},{"issue":"19","key":"10.1016\/j.atherosclerosis.2025.120523_bib3","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1001\/archinte.166.19.2073","article-title":"High-sensitivity C-reactive protein, lipoprotein-associated phospholipase A2, and outcome after ischemic stroke","volume":"166","author":"Elkind","year":"2006","journal-title":"Arch Intern Med"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2025.120523_bib4","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s11886-999-0066-0","article-title":"The role of C-reactive protein in cardiovascular disease risk","volume":"1","author":"Albert","year":"1999","journal-title":"Curr Cardiol Rep"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2025.120523_bib5","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1161\/CIRCRESAHA.115.306301","article-title":"Endothelial cell dysfunction and the pathobiology of atherosclerosis","volume":"118","author":"Gimbrone","year":"2016","journal-title":"Circ Res"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2025.120523_bib6","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.jacc.2015.11.037","article-title":"A Test in context: High-Sensitivity C-Reactive protein","volume":"67","author":"Ridker","year":"2016","journal-title":"J Am Coll Cardiol"},{"issue":"9709","key":"10.1016\/j.atherosclerosis.2025.120523_bib7","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/S0140-6736(09)61717-7","article-title":"C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis","volume":"375","author":"Kaptoge","year":"2010","journal-title":"Lancet"},{"issue":"14","key":"10.1016\/j.atherosclerosis.2025.120523_bib8","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1056\/NEJM199704033361401","article-title":"Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men","volume":"336","author":"Ridker","year":"1997","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2025.120523_bib9","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1056\/NEJM200003233421202","article-title":"C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women","volume":"342","author":"Ridker","year":"2000","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.atherosclerosis.2025.120523_bib10","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1007\/s00392-024-02471-w","article-title":"Inflammatory risk and clinical outcomes according to polyvascular atherosclerotic disease status in patients undergoing PCI","volume":"114","author":"Bay","year":"2025","journal-title":"Clin Res Cardiol"},{"issue":"8","key":"10.1016\/j.atherosclerosis.2025.120523_bib11","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1056\/NEJMoa1809798","article-title":"Low-Dose methotrexate for the prevention of atherosclerotic events","volume":"380","author":"Ridker","year":"2019","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2025.120523_bib12","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.3390\/jcm9041033","article-title":"Residual inflammation indicated by high-sensitivity C-Reactive protein predicts worse long-term clinical outcomes in Japanese patients after percutaneous coronary intervention","volume":"9","author":"Takahashi","year":"2020","journal-title":"J Clin Med"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2025.120523_bib13","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"CANTOS trial group. Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N Engl J Med"},{"issue":"21","key":"10.1016\/j.atherosclerosis.2025.120523_bib14","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1056\/NEJMoa0807646","article-title":"JUPITER Study Group. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein","volume":"359","author":"Ridker","year":"2008","journal-title":"N Engl J Med"},{"issue":"20","key":"10.1016\/j.atherosclerosis.2025.120523_bib15","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1056\/NEJMoa021993","article-title":"Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events","volume":"347","author":"Ridker","year":"2002","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2025.120523_bib16","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa042378","article-title":"Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22) investigators. C-reactive protein levels and outcomes after statin therapy","volume":"352","author":"Ridker","year":"2005","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2025.120523_bib17","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1161\/01.CIR.0000052939.59093.45","article-title":"Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association","volume":"107","author":"Pearson","year":"2003","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.atherosclerosis.2025.120523_bib18","first-page":"e596","article-title":"ACC\/AHA Guideline on the primary prevention of cardiovascular disease: a report of the American college of Cardiology\/American Heart Association task force on clinical practice Guidelines","volume":"140","author":"Arnett","year":"2019","journal-title":"Circulation"},{"issue":"36","key":"10.1016\/j.atherosclerosis.2025.120523_bib19","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1093\/eurheartj\/ehae177","article-title":"2024 ESC Guidelines for the management of chronic coronary syndromes","volume":"45","author":"Vrints","year":"2024","journal-title":"Eur Heart J"},{"issue":"46","key":"10.1016\/j.atherosclerosis.2025.120523_bib20","doi-asserted-by":"crossref","first-page":"4101","DOI":"10.1093\/eurheartj\/ehy633","article-title":"Residual inflammatory risk and the impact on clinical outcomes in patients after percutaneous coronary interventions","volume":"39","author":"R Kalkman","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.atherosclerosis.2025.120523_bib21","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehaf196","article-title":"Residual cholesterol and inflammatory risk in statin-treated patients undergoing percutaneous coronary intervention","author":"Bay","year":"2025","journal-title":"Eur Heart J"},{"issue":"10384","key":"10.1016\/j.atherosclerosis.2025.120523_bib22","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/S0140-6736(23)00215-5","article-title":"PROMINENT, REDUCE-IT, and STRENGTH Investigators. Inflammation and cholesterol as predictors of cardiovascular events among patients receiving statin therapy: a collaborative analysis of three randomised trials","volume":"401","author":"Ridker","year":"2023","journal-title":"Lancet"},{"issue":"22","key":"10.1016\/j.atherosclerosis.2025.120523_bib23","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1056\/NEJMoa2405182","article-title":"Inflammation, cholesterol, Lipoprotein(a), and 30-Year cardiovascular outcomes in women","volume":"391","author":"Ridker","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2025.120523_bib24","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehaf209","article-title":"Low-density lipoprotein cholesterol, C-reactive protein, and lipoprotein(a) universal one-time screening in primary prevention: the EPIC-Norfolk study","author":"Kraaijenhof","year":"2025","journal-title":"Eur Heart J"},{"issue":"18","key":"10.1016\/j.atherosclerosis.2025.120523_bib25","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1615664","article-title":"FOURIER Steering Committee and investigators. Evolocumab and clinical outcomes in patients with cardiovascular disease","volume":"376","author":"Sabatine","year":"2017","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2025.120523_bib26","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1161\/CIRCULATIONAHA.118.034032","article-title":"Inflammatory and cholesterol risk in the FOURIER trial","volume":"138","author":"Bohula","year":"2018","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2025.120523_bib27","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1161\/CIRCULATIONAHA.118.034645","article-title":"Residual inflammatory risk on treatment with PCSK9 inhibition and Statin therapy","volume":"138","author":"Pradhan","year":"2018","journal-title":"Circulation"},{"issue":"38","key":"10.1016\/j.atherosclerosis.2025.120523_bib28","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1093\/eurheartj\/ehad191","article-title":"2023 ESC Guidelines for the management of acute coronary syndromes","volume":"44","author":"Byrne","year":"2023","journal-title":"Eur Heart J"},{"issue":"13","key":"10.1016\/j.atherosclerosis.2025.120523_bib29","first-page":"e771","article-title":"ACC\/AHA\/ACEP\/NAEMSP\/SCAI Guideline for the management of patients with acute coronary syndromes: a report of the American college of Cardiology\/American Heart Association Joint Committee on clinical practice Guidelines","volume":"151","author":"Rao","year":"2025","journal-title":"Circulation"},{"issue":"26","key":"10.1016\/j.atherosclerosis.2025.120523_bib30","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1093\/eurheartj\/ehaf174","article-title":"Long-term trials of colchicine for secondary prevention of vascular events: a meta-analysis","volume":"46","author":"Samuel","year":"2025","journal-title":"Eur Heart J"},{"issue":"11","key":"10.1016\/j.atherosclerosis.2025.120523_bib31","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.012638","article-title":"hsCRP level and the risk of death or recurrent cardiovascular events in patients with myocardial infarction: a healthcare-based Study","volume":"8","author":"Carrero","year":"2019","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2025.120523_bib32","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.cardiores.2006.03.004","article-title":"C-reactive protein in atherosclerosis: a causal factor?","volume":"71","author":"Paffen","year":"2006","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.atherosclerosis.2025.120523_bib33","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.amjcard.2021.12.042","article-title":"Effect of elevated C-Reactive protein on outcomes after complex percutaneous coronary intervention for Angina Pectoris","volume":"168","author":"Camaj","year":"2022","journal-title":"Am J Cardiol"},{"issue":"8","key":"10.1016\/j.atherosclerosis.2025.120523_bib34","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1038\/s41591-024-03043-1","article-title":"IL-6 inhibition with clazakizumab in patients receiving maintenance dialysis: a randomized phase 2b trial","volume":"30","author":"Chertow","year":"2024","journal-title":"Nat Med"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915025014212?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915025014212?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T04:26:21Z","timestamp":1780633581000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915025014212"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":34,"alternative-id":["S0021915025014212"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2025.120523","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical impact of systemic inflammation across different high-sensitivity C-reactive protein cutoffs in patients undergoing percutaneous coronary intervention","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2025.120523","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"120523"}}